Celldex Therapeutics Inc (NASDAQ:CLDX) - Share price - Overview

Stock Report

Celldex Therapeutics Inc CLDX

Last Price
$0.64

Day Change
-0.02|-3.35%

As of 24/05/2018
17:36:28 EDT | USD
Minimum 15 Minutes Delay.

Last Close0.66
Day Range0.62 - 0.68
Mkt Cap91.43Mil
52-Wk Range0.62 - 3.26
Yield %-
ISINUS15117B1035
Volume2,979,800
P/E-0.50
P/S5.55
P/CF-0.92

Share Price

Financials
201520162017
More ...
Income Statement
Revenue5.486.7912.74
Operating Income-129.54-132.92-109.33
Net Income-127.20-128.53-93.03
Basic EPS-1.31-1.27-0.72
Avg. Diluted Shares Outstanding97102129
Balance Sheet
Current Assets294.94195.57144.76
Non Current Assets42.65187.79170.87
Total Assets337.58383.36315.62
Current Liabilities30.2435.2227.74
Total Liabilities---
Total Equity290.11265.43236.37
Cash Flow
Operating Cash Flow-98.89-113.04-99.93
Capital Expenditure-4.88-2.75-1.79
Free Cash Flow-103.76-115.79-101.72

In millions, except "Basic EPS". Currency is USD.

Company Profile

Celldex Therapeutics Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

197
Key Stats
More ...
Price/Earning TTM-0.52
Price/Book0.71
Price/Sales TTM6.66
Rev Growth (3 year avg)52.60
EPS Growth (3 year avg)-
Operating Margin % TTM-857.94
Net Margin % TTM-730.06
ROE TTM-37.08
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.